Christoph Lengauer - Chief Scientific Officer, Blueprint Medicines Corp

As of April 14, 2016


Christoph Lengauer Net Worth

  • Net worth is estimated to be at least $11.97M
  • Owns at least 56,657 units of Blueprint Medicines Corp stock
  • Sold an estimated value of $3.27M in the last year at Blueprint Medicines Corp

Christoph Lengauer Trading

  • Largest sale of shares was 84,998 units , worth over $1.79M on November 4, 2015
  • In total has made about 6 transactions over a year
  • Usually trades in April, with the busiest year in 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christoph Lengauer Mailing Address

  • Mailing address is Blueprint Medicines Corp. 215 First Street, Suite 340/350 Cambridge MA 02142 MA

Blueprint Medicines Corp Executive Compensation

Name
Year
Salary
Total
Jeffrey W. Albers 2020 $645,000 $6,344,667
Jeffrey W. Albers 2019 $590,000 $9,362,371
Jeffrey W. Albers 2018 $541,144 $9,740,799
Michael Landsittel 2020 $379,575 $2,014,974
Michael Landsittel 2019 $345,000 $1,958,720
Michael Landsittel 2018 $281,678 $1,740,610
Fouad Namouni, M.D. 2020 $186,154 $6,668,732
Fouad Namouni, M.D. 2019 - -
Fouad Namouni, M.D. 2018 - -
Kathryn Haviland 2020 $460,944 $2,363,556
Kathryn Haviland 2019 $431,830 $3,090,423
Kathryn Haviland 2018 $392,589 $2,601,762
Tracey L. McCain, Esq. 2020 $453,301 $2,346,428
Tracey L. McCain, Esq. 2019 $437,972 $2,900,568
Tracey L. McCain, Esq. 2018 $425,216 $2,647,962
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1597264/000155837021004557/tmb-20210602xdef14a.htm

Blueprint Medicines Corp Insider Trading

  • The most recent transaction was 11,833 units sold on September 17, 2021 by Becker Hewes worth over $1.2M
  • In the last 6 years, insiders at Blueprint Medicines Corp sold an estimated value of $154.57M and bought an estimated value of $14.18M
  • The most active traders are Jeffrey Albers, CEO and President,  Kate Haviland, Chief Operating Officer,  and Ariel Hurley, Principal Accounting Officer
  • Insider trading is most common in June, with the busiest year in 2020

Blueprint Medicines Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1